Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 18/20 | 0.46 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14146298 | 0.88 | CALCRL (0.44) | CALCRLCRBNCYP3A4 | |
| SCHEMBL15701574 | 0.88 | CALCRL (0.44) | CALCRLCRBNCYP3A4 | |
| SCHEMBL13062472 | 0.78 | CALCRL (0.38) | CALCRLCRBN | |
| SCHEMBL13791580 | 0.74 | CALCRL (0.70) | CALCRLCYP3A4 | |
| SCHEMBL440887 | 0.71 | CALCRL (0.58) | CALCRL | |
| SCHEMBL440054 | 0.71 | CALCRL (0.58) | CALCRL | |
| SCHEMBL14146293 | 0.70 | CALCRL (0.56) | CALCRL | |
| SCHEMBL440106 | 0.70 | CALCRL (0.56) | CALCRL | |
| SCHEMBL13062468 | 0.69 | CALCRL (0.39) | CALCRLCRBNCYP3A4 | |
| SCHEMBL13792073 | 0.69 | CALCRL (0.70) | CALCRLCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140128375-A1 | BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. | 2014-05-08 | — | — | US | disclosed |
| WO-2008085317-A1 | BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128375-A1 | BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | BDKRB1, BDKRB2, CALCRL | CALCRL 3/4885CRBN 2273/4885CYP3A4 1522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.